$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Heterologous Expression of Interferon α-2b in Lactococcus lactis and its Biological Activity against Colorectal Cancer Cells 원문보기

Microbiology and biotechnology letters = 한국미생물·생명공학회지, v.49 no.1, 2021년, pp.75 - 87  

Meilina, Lita (Research Center for Biotechnology, Indonesian Institute of Science (LIPI)) ,  Budiarti, Sri (School of Biotechnology, IPB University) ,  Mustopa, Apon Zaenal (Research Center for Biotechnology, Indonesian Institute of Science (LIPI)) ,  Darusman, Huda Shalahudin (Primate Study Center, IPB University) ,  Triratna, Lita (Research Center for Biotechnology, Indonesian Institute of Science (LIPI)) ,  Nugraha, Muhammad Ajietuta (Departement of Biochemistry, Faculty of Mathematics and Natural Science, IPB University) ,  Bilhaq, Muhammad Sabiq (Faculty of Technobiology, Sumbawa University of Technology) ,  Ningrum, Ratih Asmana (Research Center for Biotechnology, Indonesian Institute of Science (LIPI))

Abstract AI-Helper 아이콘AI-Helper

Type I Interferons (IFNα) are known for their role as biological anticancer agents owing to their cell-apoptosis inducing properties. Development of an appropriate, cost-effective host expression system is crucial for meeting the increasing demand for proteins. Therefore, this study aims to d...

주제어

표/그림 (10)

참고문헌 (50)

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. 2010. Estimates of worldwide burden of cancer in 2008. Int. J. Cancer. 127: 2893-2917. 

  2. World Health Organization. 2019. Indonesia source GLOBOCAN 2018. Int. Agency Res. Cancer. 256: 1-2. 

  3. Elsaleh H, Grieu F, Joseph DJ, Iacopetta B. 2001. Molecular epidemiology of colorectal cancer. Int. J. Radiat. Oncol. 51: 260-261. 

  4. Pardini B, Kumar R, Naccarati A, Novotny J, Prasad RB, Forsti A, et al. 2011. 5-Fluorouracil-based chemotherapy for colorectal cancer and MTHFR/MTRR genotypes. Br. J. Clin. Pharmacol. 72: 162-163. 

  5. Wells JM, Mercenier A. 2008. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nature 6: 349-362. 

  6. Ningrum RA. 2014. Human Interferon Alpha-2b: A Therapeutic Protein for cancer treatment. Scientifica 2014: 1-9. 

  7. Ningrum RA, Wisnuwardhani PH, Santoso A, Herawati N. 2015. Antiproliferative activity of recombinant human interferon alpha2b on estrogen positive human breast cancer MCF-7 cell line. Indones J. Pharm. 26: 86. 

  8. Eguchi H, Nagano H, Yamamoto H, Miyamoto A, Kondo M, Dono K, et al. 2000. Augmentation of antitumor activity of 5-fluorouracil by interferon α is associated with up-regulation of p27Kip1 in human hepatocellular carcinoma cells 1. Clin. Cancer Res. 6: 2881-2890. 

  9. Badan Pengawasan Obat dan Makanan Republik Indonesia. 2005. Peraturan Badan pengawas Obat dan Makanan Republik Indonesia. Badan Pengawas Obat. dan. Makanan. 53: 1689-1699. 

  10. Kementerian Kesehatan Republik Indonesia. 2015. Rencana Strategis Kementerian Kesehatan Tahun 2015-2019, Kepmenkes RI Nomor HK.02.02/Menkes/52/2015. Kemenkes RI. 248. 

  11. Ningrum RA. 2017. Human interferon Alpha2a as anti Hepatitis B and C. Indones. J. Clin. Pharm. 6: 298-310. 

  12. Gull I, Samra ZQ, Aslam MS, Athar MA. 2013. Heterologous expression, immunochemical and computational analysis of recombinant human interferon alpha 2b. Springerplus 2: 264. 

  13. Noureddin M, Ghany MG. 2010. Pharmacokinetics and pharmacodynamics of peginterferon and ribavirin: implications for clinical efficacy in the treatment of chronic Hepatitis C. Gastroenterol Clin. North Am. 39: 649-6580. 

  14. Zhao HL, Xue C, Du JL, Ren M, Xia S, Liu ZM. 2012. Balancing the pharmacokinetics and pharmacodynamics of interferon-α2b and human serum albumin fusion protein by proteolytic or reductive cleavage increases its in vivo therapeutic efficacy. Mol. Pharm. 9: 664-6702. 

  15. Ningrum RA, Wardhani WK, Wahyuni I, Mustopa AZ. 2018. Optimization of expression condition, two dimensional and melting point-based characterization of recombinant human interferon alpha-2a fusion and non fusion forms. Ann. Bog. 22: 57. 

  16. Ningrum RA, Santoso A, Herawati N. 2017. Overproduction, purification and characterization of human interferon alpha2a-human serum albumin fusion protein produced in methilotropic yeast Pichia pastoris. J. Phys. Conf. Ser. 835: 1. 

  17. Mustopa AZ, Wijaya SK, Ningrum RA, Agustiyanti DF, Triratna L, Alfisyahrin WN. 2019. The expression of codon optimised hepatitis B core antigen (HBcAg) of subgenotype B3 open reading frame in Lactococcus lactis. Microbiol. Biotechnol. Lett. 47: 449-458. 

  18. Zhoua Z, Danga Y, Zhou M, Li L, Yu CH, Fu J, et al. 2016. Codon usage is an important determinant of gene expression levels largely through its effects on transcription. Proc. Natl. Acad. Sci. USA 113: E6117-E6125. 

  19. Mustopa AZ, Mariyah S, Fatimah, Budiarti S, Murtiyaningsih H, Alfisyahrin WN. 2018. Construction, heterologous expression, partial purification, and in vitro cytotoxicity of the recombinant plantaricin E produced by Lactococcus lactis against Enteropathogenic Escherichia coli K.1.1 and human cervical carcinoma (HeLa) cells. Mol. Biol. Rep. 45: 1235-12448. 

  20. Anwar RI, Mustopa AZ, Ningrum RA. 2019. Construction and expression of indonesian hepatitis B core antigen (HBcAg) in Lactococcus lactis as potential therapeutic vaccine. Biotechnologia 100: 37-45. 

  21. Sambrook J, Green MR. 2012. Molecular Cloning: A Laboratory Manual. pp. 1616. 4th Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. 

  22. Borenfreund E, Babich H, Martin-Alguacil N. 1988. Comparisons of two in vitro cytotoxicity assays--the neutral red (nr) and tetrazolium mtt tests. Toxic. in Vitro. 2. 1: 1-6. 

  23. Bolotin A, Wincker P, Mauger S, Jaillon O, Malarme K, Weissenbach J, et al. 2001. The complete genome sequence of the lactic acid bacterium. Genome Res. 11: 731-753. 

  24. Kumaran J, Wei L, Kotra LP, Fish EN. 2007. A structural basis for interferon-α-receptor interactions. FASEB J. 21: 3288-32967. 

  25. MoBiTec. 2015. NICE. Expression System for Lactococcus lactis. Available from http://www.mobitec.com/cms/download/Handbooks/NICE_Expression_System-Handbook.pdf. Accessed Aug. 8, 2019. 

  26. Berlec A, Strukelj B. 2009. Large increase in brazzein expression achieved by changing the plasmid/strain combination of the NICE system in Lactococcus lactis. Lett. Appl. Microbiol. 48: 750-755. 

  27. Borrero J, Jimenez JJ, Gutiez L, Herranz C, Cintas LM, Hernandez PE. 2011. Use of the usp45 lactococcal secretion signal sequence to drive the secretion and functional expression of enterococcal bacteriocins in Lactococcus lactis. Appl. Microbiol. Biotechnol. 89: 131-143. 

  28. Aitken A, Learmonth MP. 2002. Protein determination by UV absorption, the protein protocols handbook. pp. 3-6. 2nd Ed. Totowa, New Jersey. 

  29. Ruiz L, Aroche K, Reyes N. 2006. Aggregation of recombinant human interferon alpha 2b in solution: Technical note. AAPS Pharm. Sci. Technol. 7: 5-9. 

  30. Viola R, Nyvall P, Pelloux J, Davies HV, Pederse M. 1999. Purification and characterisation of a novel starch synthase selective for uridine 5'-diphosphate glucose from the red alga Gracilaria tenuistipitata. Planta. 185: 143-152. 

  31. Winikoff SE, Zeh HJ, Demarco R, Lotze MT. 2006. Cytolytic Assays. pp. 827-849. Pittsburgh, USA. 

  32. Meerloo J van, Kaspers GJ, Cloos J. 2011. Cancer cell culture, MTT assay. Methods Mol. Biol. 731: 79-91. 

  33. Katla S, Karmakar B, Tadi SRR, Mohan N, Anand B, Pal U, et al. 2019. High level extracellular production of recombinant human interferon alpha 2b in glycoengineered Pichia pastoris: culture medium optimization, high cell density cultivation and biological characterization. J. Appl. Microbiol. 126: 1438-1453. 

  34. Ekowati H, Astuti I, Mustofa M. 2010. Anticancer activity of calanone on HeLa cell line. Indones J. Chem. 10: 240-244. 

  35. Suganya M, Gnanamangai BM, Ravindran B, Chang SW, Selvaraj A , Govindasamy C, et al. 2019. Antitumor effect of proanthocyanidin induced apoptosis in human colorectal cancer (HT-29) cells and its molecular docking studies. BMC Chem. 13: 1-14. 

  36. Bazhanova ED. 2005. Participation of interferon-alpha in regulation of apoptosis. J. Evol. Biochem. Physiol. 41: 127-133. 

  37. Kementerian Kesehatan Republik Indonesia. 2018. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Kanker Kolorektal: Kepmenkes RI Nomor HK.01.07/MENKES/406/2018. Kemenkes RI. 

  38. Jonasch E. 2001. Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities. Oncologist 6: 34-55. 

  39. Wang ZH, Wang YL, Zeng XY. 2014. Construction and expression of a heterologous protein in Lactococcus lactis by using the nisincontrolled gene expression system: The case of the PRRSV ORF6 gene. Genet. Mol. Res. 13: 1088-1096. 

  40. Abbas HT, Kyla-Nikkila K, Ra R, Saris PEJ. 2006. Nisin induction without nisin secretion. Microbiology 152: 1489-1496. 

  41. Mustopa AZ, Murtiyaningsih H, Fatimah, Suharsono. 2016. Cloning and heterologous expression of extracellular Plantaricin F produced by Lactobacillus plantarum S34 isolated from 'Bekasam' in Lactococcus lactis. Microbiol. Indones. 10: 95-106. 

  42. Lages AC, Mustopa AZ, Sukmarini L, Suharsono. 2015. Cloning and expression of Plantaricin W produced by Lactobacillus plantarum U10 isolate from 'Tempoyak' Indonesian fermented food as immunity protein in Lactococcus lactis. Appl. Biochem. Biotechnol. 177: 909-922. 

  43. Loir YL, Azevedo V, Oliveira SC, Freitas DA, Miyoshi A, BermudezHumaran LG, et al. 2005. Protein secretion in Lactococcus lactis: An efficient way to increase the overall heterologous protein production. Microb. Cell Fact. 4: 1-13. 

  44. Bermudez-Humaran LG, Gilbert S, Langella P, Commissaire J, Loir YL, L'Haridonr R, et al. 2003. Controlled intra- or extracellular production of staphylococcal nuclease and ovine omega interferon in Lactococcus lactis. FEMS Microbiol. Lett. 224: 307-313. 

  45. Bayat O, Baradaran A, Ariff A, Mohamad R, Rahim RA. 2014. Intra-cellular production of IFN-alpha 2b in Lactococcus lactis. Biotechnol. Lett. 36: 581-585. 

  46. Zhuang Z, Wu Z, Chen M, Wang PG. 2008. Secretion of human interferon-β 1b by recombinant Lactococcus lactis. Biotechnol. Lett. 30: 1819-1823. 

  47. Zhang Q, Zhong J, Liang X, Liu W, Huan L. 2010. Improvement of human interferon alpha secretion by Lactococcus lactis. Biotechnol. Lett. 32: 1271-1277. 

  48. Zhang Q, Zhong J, Huan L. 2011. Expression of hepatitis B virus surface antigen determinants in Lactococcus lactis for oral vaccination. Microbiol. Res. 166: 111-120. 

  49. Riss TL, Moravec RA, Niles AL, Duellman S, Benink HA, Worzella TJ, et al. 2016. Cell viability assays, pp. 295-305. Minor L, Lemmon V, Napper A, Peltier JM, Nelson H, Gal-Edd N (eds.), Assay Guidance Manual, Eli Lilly & Company and the National Center for Advancing Translational Sciences, Bethesda (MD). 

  50. Wang W, Roberts CJ. 201. Protein aggregation-Mechanisms, detection, and control. Int. J. Pharm. 550: 251-268. 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로